Senores Pharmaceuticals: Commercialisation Momentum Strengthens Outlook
Moneylife Digital Team 06 August 2026
Senores Pharmaceuticals (Senores) is a research-driven formulations company with operations across 40+ countries, focused on regulated markets (primarily US, Canada and UK) and emerging markets....
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Get access to complete archives
Rs 5000 + GST
 
 
Already a subscriber ? Log in
Acutaas Chemicals: CDMO Momentum Drives 59% Revenue Growth
Moneylife Digital Team 05 August 2026
Acutaas Chemicals Limited (Acutaas) makes advanced pharmaceutical intermediates (APIs) and specialty chemicals. Under its API segment, it manufactures molecules that are under clinical trial or which have been launched in the patented...
Bharat Electronics Sticks to 15% Revenue Growth, 28% Margin Target for FY26-27
Moneylife Digital Team 05 August 2026
Bharat Electronics Ltd (BEL) manufactures and supplies electronic equipment and systems to the defence sector. It also has a limited presence in the civilian market. The company has a strong order-book which provides revenue and...
Data Patterns: Execution Delays Weigh on Q1, Order Pipeline Remains Robust
Moneylife Digital Team 05 August 2026
Data Patterns (India) Limited (Data Patterns) is a Chennai-based defence and aerospace electronics company, incorporated in 1998. It operates in the indigenously developed defence electronics segment and brings technical experience...
IPO Review: LEAP India Ltd
Moneylife Digital Team 05 August 2026
LEAP India Limited (LIL), incorporated in 2013 and based in Mumbai, is the largest on-demand asset-pooling-provider in India’s supply-chain management sector, measured by the number of pooled assets. Operating a ‘share and reuse’...
Free Helpline
Legal Credit
Feedback